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ABSTRACT 
Kayla Vredeveld: The Relationship Between Gait Speed and Dynamic Stability Following a 4-
week Intervention in Knee Osteoarthritis Patients 
(Under the direction of Erik Hanson) 
 
PURPOSE: This study explored the relationship of both gait speed and body composition to gait 
stability following knee osteoarthritis (KOA) treatment. METHODS: 53 diagnosed KOA 
patients completed 4 weeks of therapeutic rehabilitation with testing sessions immediately before 
and after. Testing assessed self-reported disability, body composition, muscle function, and gait 
mechanics. Paired sample t-tests were completed, followed by correlations comparing gait speed, 
center of pressure, and ground reaction forces with baseline and change score values. RESULTS: 
20 meter gait speed significantly increased following intervention, while pain and self-reported 
function scores improved. Ground reaction forces showed increased acceleration and 
deceleration in the involved limb. Preliminary data showed correlation between lean mass and 
mediolateral center of pressure displacement. CONCLUSIONS: Current KOA treatments are 
able to not only improve function through increased walking speed, but also improve the ability 
to load the limb with greater ground reaction forces. Body composition data warrants further 
exploration.  
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CHAPTER 1: INTRODUCTION 
Knee osteoarthritis (KOA) is a health condition of the musculoskeletal system that affects 
12-16% of the population over 60 years old1 2. The degenerative disease is associated with other 
health conditions including cardiovascular disease, chronic obstructive pulmonary disease, 
obesity, diabetes, and depression3-8 at a rate of 50% of the KOA population9. Collectively, these 
comorbidities along with KOA lead to an increased mortality6 and decreased quality of life9 due 
to the limitations in independently completing activities of daily living. The ability to complete 
daily tasks in KOA patients is negatively effected by the resulting loss of balance, which is 
amplified by the loss of strength, muscle activation, and the compromised body composition. 
Falls are a prevalent issue in the healthy elderly, with studies reporting balance deficits as 
early as 50 years old10 and observations concluding that 1 in 3 adults over 65 years will fall over 
the course of a year11. Overall, loss of balance and falls are not only more common in KOA 
patients12-14, but also have significantly greater deficits compared to the healthy elderly 
averages12 15, with deficits increasing as the disease progresses13. Reliable measurements of 
dynamic balance are infrequent in KOA studies, but their direct relationship to the ability to 
complete activities of daily living and consequently quality of life12 15 demands that they are 
further explored. 
To quantify balance more precisely than clinical tests and to detect minimal changes, 
balance can be measured using both the position and movement of the center of pressure (COP) 
while the foot is in contact with a force plate16-19. Studies show significant increases in 
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mediolateral (ML) COP velocity and a decreased anteroposterior (AP) COP velocity in an 
unhealthy population compared to healthy matches19. This suggests that COP velocity may also 
increase in the KOA population. COP velocity is influenced by gait speed with studies showing 
COP velocity decreases when gait speed decreases in elderly subjects19 20. Although COP 
variables are altered based on foot structure, COP measurements have been shown to have 
moderate to good reliability18. 
Although obesity has been identified as a comorbidity with KOA6, it has not been 
established if changes in body composition are a potential cause or the result of KOA. Studies 
have shown that the fat mass (FM) and lean mass (LM) are significantly different in KOA 
patients compared to healthy matched subjects, but the values could not differentiate between 
mild and severe level KOA subjects21. This suggests that body composition may be just one of 
several influencing factors. In comparing men and women with KOA, it has been suggested that 
increased FM more strongly correlates with KOA in women while decreased LM is more closely 
associated in men22 23. Increased FM or decreased LM both reduce the relative force production 
of the muscles22 23 indicating that they are related to functional and balance measures, although 
KOA studies have not directly assessed these outcomes. 
As suggested by the evident changes in body composition, KOA patients have a loss of 
muscle strength, measured through maximal voluntary isometric contraction (MVIC)24. This loss 
of strength is due to both the loss of muscle mass21 23 25 and the activation of the motor units 
within the muscle26-29. The central activation ratio (CAR) measures the maximal strength 
capacity of the muscle by forcing a maximal contraction through electric stimulation, and 
comparing it to the MVIC to determine the ratio of motor units recruited. Decreased CAR in the 
quadriceps is common in KOA patients26-29, showing that even when the muscle mass is present, 
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the whole muscle is not being used. CAR of the rectus femoris has been able to differentiate 
between asymptomatic and moderate severity KOA28, with moderate KOA patients having a 
CAR below 80%27. 
Balance measures are correlated to quadriceps strength in the KOA population, making 
quadriceps function an important factor to consider when looking at function (r=0.37)15. When 
compared to healthy controls, KOA subjects have lower balance, strength, and activation 
measures14 15, confirming the existing relationship. Other studies have also shown that both 
decreased quadriceps strength and CAR are indicative of greater balance deficits in KOA 
patients15 30-32. Within the KOA population, the strength deficit and number of falls are 
significantly greater in surgical candidates compared to non-surgical patients32, suggesting that 
strength and balance continue to decrease as the disease progresses. 
To counteract the physical decline resulting from KOA, therapeutic exercise (TE) and 
transcutaneous electrical nerve stimulation (TENS) interventions have been used to not only 
attenuate pain, but also to increase quadriceps CAR with the aim of ultimately improving 
performance in activities of daily living27 33. A combination of TE+TENS was shown to be 
significantly more effective at improving CAR than TE alone27. Baseline testing measured a 
78±7% CAR in KOA patients, with a 4 week TE+TENS intervention increasing the CAR to 
94±4%27. Function and balance measures were not assessed in this study, but the literature 
suggests balance is related to CAR14. In a study that used only TE as an intervention, 
improvements for both the timed up and go test and the timed sit to stand test reached statistical 
significance34. The timed up and go test has been shown to be a valid measure of dynamic 
balance13, indicating that the subjects’ balance and lower extremity strength improved together.  
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To fully determine the results of treatment in KOA patients following an intervention, it 
must be determined not only if patients can move better, as determined by measures of strength, 
CAR, and gait speed, but also if patients are improving their dynamic stability mechanisms. COP 
measurements of sway velocity, sway path, and ML displacement can used to quantify dynamic 
gait stability so they can be compared to other changes occurring as a result of intervention. An 
increase in dynamic stability and the ability to move must occur simultaneously to ensure that 
not only are the patients able to move better, but they can move safer. 
Purpose 
1. To determine if there is a relationship between the changes in gait speed and dynamic 
stability following a 4 week therapeutic intervention in KOA patients 
2. To establish if there is a relationship between body composition and dynamic stability 
during KOA treatment 
Research Questions 
1. Is there an association between the change in gait speed and the change in COP 
measured immediately before and after a 4 week KOA treatment intervention? 
2. Is COP trajectory post intervention associated with lean mass, fat mass, CAR, or pain 
level? 
Hypotheses 
1. An improved COP trajectory will be associated with an increase in 20 meter 
maximal walking speed following a 4 week intervention. 
2. Improvement in COP trajectory after a 4 week intervention will be significantly 
correlated with an increase in lean body mass and decreased fat mass. 
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Limitations 
1. COP data will be based on the single step that contacts the force plate. 
Delimitations 
1. Subjects were limited to those able to walk without an assistive device. 
2. Subjects were excluded if they are obese (body mass index (BMI) >35). 
3. Participation was limited to subjects with moderate to severe KOA. 
Assumptions 
1. Subjects did not intentionally alter gait pattern during the testing session 
2. Subjects did not have medical problems, besides KOA, interfering with gait pattern 
3. Subjects answered self-reported data truthfully 
4. COP variables were representative of overall stability 
Significance of Study 
Since there is improved maximum gait speed and limb loading following treatment, 
maximum gait speed can be used as an outcome measure to determine if the gait pattern has 
improved in KOA patients. Likewise, the preliminary results between body composition and 
stability serves as a foundation for future studies.  
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CHAPTER 2: LITERATURE REVIEW 
KOA is one of the top five causes of disability and is associated with an early onset of the 
inability to independently complete activities of daily living, making it as debilitating as heart 
disease9 34. This separates those with KOA and the healthy aging. Risk of developing KOA 
increases with age1, so the rising number of the elderly in the United States population, which is 
expected to double by 205035, demands that more attention is given to this manageable health 
condition. Up to 50% of KOA patients have at least one other medical condition9, including 
depression, cardiovascular disease, obesity, diabetes, and chronic obstructive pulmonary 
disease3-8. In most cases, it is unknown if KOA is the cause or effect of other diseases. However, 
a few research studies have concluded that KOA is shown to be the causative factor of 
cardiovascular disease, obesity, and diabetes6. 
Falls are a prevalent issue in the healthy elderly, with studies reporting balance deficits as 
early as 50 years old10 and observations concluding that 1 in 3 adults over 65 years will fall over 
the course of a year11. From early on in gait related research, it was noted that aging brought 
about changes in the gait cycle36, usually finding a decrease in gait speed37-39. Conflicting results 
investigating the relationship between gait speed and stability have been published. Using similar 
methodology, some suggest that the decrease in walking speed is used to increase stability and 
prevent age associated falls40, while others indicate that there may be no additional stability 
gained through this mechanism20 41. 
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Similar to the general aging population, a significant decrease in gait speed has also been 
found in subjects with severe KOA28. Additionally, balance deficits are shown to be significantly 
worse in KOA patients when compared to the healthy elderly12 15, with half of KOA patients 
sustaining falls within the year prior to receiving surgical intervention32. Loss of balance and 
falls are more prevalent in KOA patients12 13 because they are exacerbated by changes in muscle 
strength and activation, especially of the quadriceps15 32 37. 
To quantify balance more precisely than clinical tests and to detect minimal changes, 
balance should be measured through COP. Not only should balance be measured using this 
method, but it should also be measured during a dynamic task, such as walking, so that the 
results are more applicable than static posture COP assessments. COP can be quantified by 
measures using both the position and velocity at any point during foot contact on the force plate 
and provide information about the dynamic stability of the individual. Although COP is 
influenced by foot structure, it has been determined that a healthy ML COP displacement covers 
18% of the foot width18. COP measures are highly reliable with ICC between 0.65 and 0.82 ML, 
and between 0.69 and 0.93 AP, indicating moderate to good reliability for COP position, with 
similar values for COP velocity18. The lower ICC in ML COP was seen primarily in the middle 
of stance phase, which is when the foot structure has the highest influence on COP18. 
Body composition changes in KOA patients are evident, but it is unclear whether they are 
the cause or effect of KOA21-23. Although not a true assessment of body composition, BMI 
calculates the ratio of body weight to height and is commonly used to determine the obesity level 
in KOA patients42-46. Studies using this methodology indicate that a BMI over 30kg/m2 increases 
KOA risk 7 to 8 times higher compared to those with a BMI less than 25kg/m2 42 43 47. 
Bioelectrical impedance analysis (BIA) is able to estimate fat mass and fat free mass and has the 
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advantage of simple testing procedures, encouraging its use in research45 46 48. Multivariate 
analyses showed that BIA estimates of LM were better predictors of KOA presence and severity 
compared to BMI46. However, in studies using both BMI and body fat percentage via BIA, an 
increased BMI indicated a greater risk of KOA compared to an increased body fat percentage45. 
These inconclusive results in the literature regarding the influence of FM and LM on KOA may 
be due to the error introduced through BIA estimations, despite using pre-assessment guidelines. 
Dual energy x-ray absorptiometry (DEXA) has been shown to provide valid and reliable 
measures of bone mineral density, FM, and LM49 50, making it the ideal method of assessing 
body composition. In the studies using DEXA in KOA, FM and LM are both significantly 
correlated with KOA, but neither could determine the severity of KOA21 22. However, the 
correlation between KOA and LM is not consistent, as other studies found no correlation 
between them23. Due to the small number of studies looking at the relationship between body 
composition and KOA, further study should be done using DEXA to quantify FM and LM to 
produce valid and reliable data. 
Without measuring total body composition, muscle atrophy has been quantified using 
quadriceps cross sectional area, which was found to be 12% smaller in older women with KOA 
compared to healthy women of the same age51. Although comparisons of healthy old and young 
women show that older women without KOA battle against loss of muscle mass, KOA diagnosis 
significantly increased the loss51. Maintaining muscle mass is important because it determines 
the maximum capacity of strength production, which is shown to be strongly linked to physical 
function25 52 53. 
Although muscle mass is significant in determining function, it is not the sole factor. In a 
study by Mizner et al. (2005), KOA patients were compared before and after total knee 
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arthroplasty and it was found that muscle mass and muscle inhibition together explained 85% of 
the strength deficit, but muscle inhibition was twice as significant as the muscle mass54. This 
shows that negating atrophy is important, but muscle inhibition must be addressed in order to 
receive the greatest benefits of therapeutic exercise and to gain the maximum pain free 
function33. 
A true maximal contraction can be produced through electric stimulation of the muscle 
during MVIC testing. The CAR is determined by comparing the MVIC to the stimulated 
maximal contraction26 27 29. It is common for KOA patients to have a CAR below 80%, meaning 
that 20% of the muscle fibers are not voluntarily recruited27. This inactivation leads to weakness 
in KOA patients that is evident in both isometric and isokinetic strength testing24. It was 
observed that 50% of subjects with mild KOA were unable to fully activate the quadriceps55. 
When muscle fibers are not voluntarily fired, they are not able to be recruited to complete daily 
activities. However, when quadriceps activation is increased through an exercise intervention, a 
significant increase in MVIC results29. 
This weakness that is due to both a loss of muscle mass and a loss of muscle activation 
alters the gait pattern in KOA patients24 28 29 33 51 54. Just as weakness effects function, it also 
effects balance scores in KOA patients31. When compared to healthy controls, KOA subjects 
have lower static balance, strength, and activation measures14, confirming the existing 
relationship. Several studies have also shown that both decreased quadriceps strength and CAR 
are indicative of greater balance deficits in KOA patients15 30 31. Within the KOA population 
itself, the quadriceps strength deficit is significantly greater in surgical KOA candidates 
compared to non-surgical KOA patients and increases their fall prevalence from 30% to 48%32. 
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KOA directly decreases physical function, specifically gait function, due to 
accompanying knee pain56-58. Pain levels are strongly associated with the severity of KOA59. 
However, there is evidence that these pain levels, based on self-reported pain using a visual 
analog scale (VAS), are manageable because a hyaluronate injection intervention significantly 
decreased pain after 5 weeks56. KOA pain inhibits a normal gait pattern, as the expectant double 
peak typically seen in the ground reaction forces of healthy individuals is not present KOA 
patients57. Instead, KOA patients exhibit a blunted ground reaction force response and alter their 
mechanics to reduce loading forces in the lower extremities, shown in both level ground 
walking57 and during more demanding tasks such as descending stairs60. Hyaluronate injections, 
used in KOA to reduce pain levels, allows the ground reactions forces to be restored to those of a 
healthy individual following a 5-week intervention of hyaluronate injections56 57.  
Current treatments for KOA include both TE and TENS interventions with the ultimate 
goal of increasing normal, pain free function in KOA patients. The focus of TE is typically to 
increase lower extremity strength, especially in the quadriceps34. Although TE can increase the 
strength of the muscle by increasing the size and number of muscle fibers61, it may not increase 
the amount of muscle fibers voluntarily contracting, leaving the patient prone to both losses of 
muscular strength and muscular atrophy62. Traditionally, TENS was used in treatment to reduce 
pain63-65. However, more recent applications of TENS have been used to increase the CAR of the 
quadriceps27 29 33 63 66 67. By applying TENS to increase CAR, the muscle’s true potential may be 
able to be reached. 
While TENS as an intervention for increasing CAR and strength shows potential and 
should continue to be developed, there is also evidence suggesting that TENS may directly 
increase balance. In a healthy population, TENS applied to the gastrocnemius was shown to have 
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an immediate acute effect on balance, quantified by a pressure mat68. Park et al. compared 
TE+TENS to a TE+shamTENS group of stroke patients, finding that the TENS group had 
greater improvements in balance after a 6 week intervention69. The influence of TENS on 
balance needs to be further explored and tested in the KOA population because of its potential to 
decrease fall risk and increase safe participation in activities of daily living. 
Research shows that KOA patients are negatively effected by balance deficits, which are 
related to the compromised body composition and strength. Treatments targeting strength may 
result in an improvement in body composition as well as physical function. However, in order to 
benefit KOA patients to the greatest extent, dynamic stability must also increase to lower fall risk 
while completing these tasks. By ensuring KOA patients are functioning at a higher level 
physically and are more stable during these activities, the quality of life with KOA can improve 
greatly. 
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CHAPTER 3: METHODOLOGY 
Research Design Overview 
The primary purpose of this study was to determine if a relationship exists between the 
change in gait speed and the change in dynamic stability following an intervention. The 
secondary purpose was to establish if there is a relationship between body composition and 
dynamic stability following KOA treatment. Subjects went through a 4 week intervention with 
baseline and post-intervention testing sessions. 
Subjects 
 All subjects in this study were diagnosed radiographically with moderate to severe KOA 
on the Kellgren-Lawrence (KL) scale. Subjects were recruited through referral by their 
orthopaedic physician at the Orthopaedic Clinic. Subjects were eligible for inclusion if they meet 
all of the following criteria: 
 Between the ages of 40 and 75 years old 
 Exhibit symptomatic KOA, which we will define as a normalized, person based, 
Western Ontario and McMaster Universities Arthritis Index (WOMAC) function 
subscale score > 31 
 Radiographic evidence of tibiofemoral osteoarthritis (2-4 on the KL scale)  
 Neuromuscular activation deficits, defined as central activation ratio of less than 90% 
± 2% in the involved leg 
Subjects were excluded from the study if any of the following were present: 
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 Diagnosed with a cardiovascular condition restricting exercise 
 Have had a corticosteroid or hyaluronic acid injection in the involved knee in the 
previous 14-days 
 Have a pacemaker 
 Have a neurodegenerative condition 
 Have rheumatoid arthritis 
 Have cancer 
 Have a neural sensory dysfunction over the knee 
 Have a BMI over 35 
 Have a history of lower extremity orthopaedic surgery in the past year 
 Have a history of a traumatic knee injury in the past 6 months 
 Have any history of a total knee arthroplasty in either extremity 
 Have a diagnosed, non-reconstructed knee ligament tear 
 Need an assistive device to walk  
 Currently pregnant or planning to become pregnant while enrolled in the study 
Prior to data collection, subjects signed an informed consent form (Appendix A) which was 
approved by the University of North Carolina Biomedical Institutional Review Board. 
Procedures 
After a physician confirmed the OA diagnosis, a member of the research team explained 
the goals of the study. Subjects were also recruited through the Carolina Data Warehouse for 
Health and UNC-Hospital’s Database. These subjects were contacted via mail with an 
informational packet. A research team member then called them to follow-up. If subjects were 
interested in participating in the study, they were screened either in the lab or over the phone for 
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demographic information and self-reported function based on the Functional subscale of the 
WOMAC Questionnaire. Subjects were also able to ask any questions related to involvement in 
the study. If interested subjects were still eligible for the study, an appointment in the 
Neuromuscular Research/Sports Medicine Research Laboratory was made. At this appointment, 
subjects signed the informed consent, and completed the baseline testing before their first 
appointment at UNC Meadowmont Physical Therapy Clinic. 
Intervention Groups 
The subjects were randomized into 1 of 3 treatment groups before the first PT visit.  
Therapeutic Exercise 
Subjects in this group completed all 10 visits at UNC Meadowmont, participating in TE 
with the goal of increasing lower extremity strength and function. Each visit lasted 
approximately 45 minutes, and subjects completed 2-3 sessions a week, totaling 10 over a 4 
week period. TE included flexibility exercises, lower extremity strengthening exercises, and 
balance training, with all subjects receiving the same protocol, but progressing on an individual 
basis. 
Therapeutic Exercise + TENS 
This group completed the same TE as the control group, but also used a TENS unit 
(EMPI, Inc., St. Paul, MN; TENS Manual). Subjects were educated on how to use the system 
during the first physical therapy visit and given an instruction manual for increasing dosage 
throughout the 4 weeks. Subjects were instructed to apply TENS for approximately 8 hours per 
day, when they are most active. 
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Therapeutic Exercise +shamTENS 
Subjects in this group completed the same TE program, and were given a TENS unit 
programmed to discontinue current output after 20 seconds. Subjects were instructed similarly to 
the TENS group, but were told that it is normal to not feel the current output after application. 
No instructions for increasing dosage were given. 
Outcome Measures 
 At all lab visits, subjects underwent the same testing procedures, completed by a blinded 
member of the research team. 
Visual Analog Scales (VAS) were used for current level of knee pain. A solid line from 0 
to 100 was shown to the subject, and they were asked to mark how they currently felt. A score of 
100 indicated “worst pain imaginable”, and a score of 0 indicated “no pain”. Distance was 
measured from 0 to the line drawn and reported in centimeters. 
Body Composition 
 A subpopulation in the study completed body composition testing via DEXA (DEXA; 
GE Lunar DEXA, GE Medical Systems Ultrasound & Primary Care Diagnostics, Madison, WI, 
USA), using the encore software for analysis (enCORE Software Version 16). Subjects adhered 
to the following pre-assessment guidelines: 
 Remove shoes and any jewelry prior to testing 
 Two hours fasted and adequately hydrated 
A member of the research team positioned each patient in a straight line within the table 
boundaries. Subjects were asked to lie still for approximately 10 minutes while the scan was 
completed. Measurements of total body and lower extremity total mass, fat mass, fat percentage, 
and lean mass were recorded for analysis. 
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Muscle Function 
Subjects were positioned on the isokinetic dynamometer, using straps to secure their 
torso, thigh, and lower leg to the device. The knee was in 90º of flexion and the movement arm 
was in a fixed position to test strength isometrically. Two electrodes were placed over the 
quadriceps. The subjects were instructed to ‘kick out’ in order to flex the quadriceps as quickly 
and as strongly as possible while keeping their arms crossed over their chest to prevent accessory 
movement. A practice trial was done at approximately 25, 50, and 75% of the subject’s perceived 
maximum, then three maximal trials were completed and the average score was recorded. For the 
next 2 trials, an electrical stimulus was given after the torque plateaus at the previously 
determined average MVIC. The CAR was calculated by comparing the voluntary force to the 
electrically stimulated force production. 
Gait Biomechanics 
Subjects walked along a 6m walkway at a comfortable, self-selected speed. A minimum 
of 5 practice trials were done to determine the average preferred speed given in real time through 
2 sets of timing gates (TF100, Trac Tronix, Lenexa, Kansas, United States). Five valid trials for 
each limb were completed for data collection. For a trial to be valid, subjects had to fully contact 
the force plate and be within ± 5% of their preferred gait speed.  
Force Plates 
 While walking at their preferred speed, subjects crossed over embedded Bertec force 
plates (40x60cm, FP406010, Bertec Corporation, Columbus, Ohio, United States). Ground 
reaction forces were sampled at 1200Hz, filtered using a dual pass 4th order Butterworth filter 
with a 12Hz cut off, using Vicon Nexus v1.7.1 motion capture software (Vicon Motion Systems, 
Los Angeles, CA, USA). This data was uploaded to The Motion Monitor v9.0 software system 
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(Innovative Sports Training, Inc., Chicago, IL, USA) for analysis. The x-axis indicated 
anteroposterior and the y-axis indicated mediolateral movement of the COP relative to the 
participant. Once the data was verified and analyzed in The Motion Monitor, the exported results 
were run through Matlab (The Mathworks, Inc., R2016a) where the mean for each of the 
following variables was determined using the 3 middle trials. Trials were substituted if there 
were ground reaction forces (GRF) on both plates, indicating their foot was not fully on the plate. 
 Stance time 
 COP ellipse area 
 COP sway path 
 COP sway velocity 
 ML excursion 
 M displacement 
 L displacement 
 Vertical ground reaction force (VGRF) maximum 
 Anteroposterior ground reaction force (APGRF) maximum and minimum 
 Mediolateral ground reaction force (APGRF) maximum and minimum 
All GRF variables were calculated for the first and second 50% of stance phase. Initial 
contact was defined as the point at which the ground reaction force is greater than 10N, and the 
toe off was the point at which the force is less than 10N. 
Maximum Gait Speed 
 20 meter walk test was completed at the subject’s maximum speed. Subjects were 
instructed to walk from the starting line to the cones placed 20 meters away as quickly as they 
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safely could without running. Three trials were completed and the average score was used in the 
data analysis. 
Statistical Analysis 
 SPSS 23.0 (SPSS INC, Chicago, Ill) was used for all statistical calculations with 
statistical significance set a-priori at p<0.05. Analysis for outliers was completed by determining 
the interquartile range for the 20 meter walk test. One outlier was found and removed for all 
statistical analysis. The descriptive characteristics were reported as the mean ± standard 
deviation. A series of T-tests were run to determine if there were significant changes following 
intervention. In order to answer research question one, a correlation analysis was done 
comparing baseline and change scores of gait speed and the COP variables. A partial correlation 
was then completed controlling for the baseline maximum gait speed. For the second research 
question, a correlation analysis was done for the DEXA subjects between the COP variables and 
the subject characteristics. 
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CHAPTER 4: RESULTS 
Fifty three older subjects participated in this study who were, on average, overweight, 
diagnosed radiographically with moderate to severe KOA and experiencing mild to moderate 
pain and dysfunction (Table 1), one subject was removed as an outlier upon statistical analysis. 
In a sub-group of individuals with body composition scans (N=7), subjects were found to be 
obese. No significant differences between the DEXA and no DEXA groups were found. 
Table 1. Participant characteristics (N=53) 
 Total No DEXA DEXA* 
 Mean (SD) Mean (SD) Mean (SD) 
Age (y) 62 (7) 62 (7) 61 (10) 
Sex (% female) 25 (47) 23 (51) 3 (43) 
Height (cm) 173.7 (10.5) 173.8 (10.5) 173.5 (12.1) 
Mass (kg) 85.5 (15.2) 85.5 (15.6) 84.3 (14.1) 
BMI (kg/m2) 28.3 (3.8) 28.3 (4.0) 27.9 (2.6) 
KOA condition (% bilateral) 39 (73.6) 34 (75.6) 71.4 
KL Scale Score 2.8 (0.6) 2.8 (0.6) 2.7 (0.4) 
WOMAC Score 48.1 (13.1) 48.5 (13.8) 43.9 (7.9) 
CAR 0.77 (0.13) 0.77 (0.12) 0.74 (0.16) 
Fat Mass (kg) - - 64.4 (13.2) 
Body Fat (%) - - 36.3 (8.8) 
*subpopulation of N=7 
DEXA=dual energy x-ray absorptiometry; BMI=body mass index; KOA=knee 
osteoarthritis; KL=Kellgren-Lawrence; WOMAC=Western Ontario and McMaster 
Universities Arthritis Index; CAR=central activation ratio 
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The changes in gait function following a 4 week intervention are displayed in Table 2. 
Maximum gait speed, represented by the 20 meter walk test, improved significantly following 
intervention (p<0.001). COP sway velocity and L displacement both significantly increased with 
intervention, while there was a trend for higher COP sway path (p=0.055). GRFs were measured 
as the vertical (V), mediolateral (ML), and anteroposterior (AP) forces. Significant increases in 
minimum MLGRF during the first and second 50% of stance were found. Significant changes 
Table 2. Gait characteristics before and following a 4 week intervention 
 Baseline 4 Week % Change p value 
Pain (VAS; cm) 4.1 (2.6) 2.9 (2.5) -27.9 0.008 
20 meter walk test (s) 11.6 (2.1) 11.1 (2.1) -4.4 <0.001 
WOMAC Score 48.1 (13.2) 30.7 (15.2) -34.9 <0.001 
Stance Time (s) 0.76 (0.07) 0.74 (0.06) -2.7 0.004 
Ellipse Area (cm2) 72.8 (24.2) 73.1 (21.1) 0.4 0.908 
Sway Path (cm) 72.5 (9.6) 75.9 (9.6) 4.3 0.047 
Sway Velocity (cm/s) 96.9 (15.6) 103.5 (16.3) 6.8 0.013 
ML Excursion (cm) 5.6 (1.5) 5.8 (1.6) 2.6 0.490 
M Displacement (cm) 3.3 (1.7) 2.8 (1.9) -13.1 0.156 
L Displacement (cm) -2.3 (1.6) -2.9 (2.1) 24.4 0.015 
VGRF Maximum 1 (kg/N) 1.067 (0.072) 1.080 (0.075) 1.2 0.089 
VGRF Maximum 2 (kg/N) 1.023 (0..058) 1.024 (0.069) 0.2 0.938 
MLGRF Maximum 1(kg/N) 0.064 (0.018) 0.064 (0.018) 1.0 0.853 
MLGRF Maximum 2 (kg/N) 0.058 (0.019) 0.057 (0.017) -1.2 0.542 
MLGRF Minimum 1(kg/N) -0.037 (0.023) -0.040 (0.025) 9.8 0.045 
ML GRF Minimum 2 (kg/N) -0.006 (0.009) -0.008 (0.009) 39.8 0.007 
APGRF Maximum 1 (kg/N) 0.036 (0.018) 0.036 (0.019) -0.2 0.903 
APGRF Maximum 2 (kg/N) 0.165 (0.035) 0.172 (0.034) 4.2 0.005 
APGRF Minimum 1 (kg/N) -0.166 (0.038) -0.176 (0.039) 6.6 0.002 
APGRF Minimum 2 (kg/N) -0.014 (0.010) -0.014 (0.010) 2.3 0.732 
Mean (SD) 
VAS=visual analog scale; WOMAC=Western Ontario and McMaster Universities Arthritis 
Index; ML=mediolateral; 1=first 50% of stance phase; 2=second 50% of stance phase 
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were also found in APGRF with the minimum during the first 50% of stance time and the 
maximum during the second 50% increasing following intervention. 
To determine the relationship between gait speed and stability in KOA patients (research 
question 1), correlation coefficients were computed between 20 meter walk test score and COP 
variables using baseline values. This analysis showed that maximum gait speed was correlated 
with sway velocity (r(53)=-0.318, p=0.02). No significant correlations were found between 
maximum gait speed and ML COP position at baseline. 
Although initial baseline analysis results did not show meaningful significance, the 
relationship was further explored by computing correlation coefficients comparing change scores 
of maximum gait speed, COP variables, and GRF variables (Table 3). No significant correlations 
were found between the 20 meter walk test and any COP variables, data is not reported. Stance 
time was significantly correlated with four and approached significance with one of ten GRF 
variables. When controlling for baseline maximum gait speed, the correlation between the 
change in the 20 meter walk test and AP GRF maximum during the first 50% of gait becomes 
significant (r(53)=0.289, p=0.037), while the other values remained significant.  
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In order to fully answer research question 2 and determine the relationship between the 
participant characteristics and gait cycle, correlation coefficients between baseline COP variables 
and subject characteristics were computed (Table 4). No relationships between any of the 
variables were observed. 
In the subpopulation that completed DEXA scans (n=7), both total body lean mass and 
lean mass in the legs showed a significant correlation to M and L COP displacement (Table 5). A 
Table 3. Change score Pearson’s correlations between COP and GRF variables 
 Stance Time (s) Ellipse Area (cm2) Sway Path (cm) 
Sway Velocity 
(cm/s) 
V GRF Maximum 1 -0.25 0.20 0.25 0.27 
V GRF Maximum 2 -0.05 0.26 0.04 0.06 
ML GRF Maximum 1 -0.27+ 0.20 0.12 0.17 
ML GRF Maximum 2 -0.35* 0.21 0.19 0.25 
ML GRF Minimum 1 0.05 0.03 -0.00 -0.02 
ML GRF Minimum 2 -0.14 0.09 0.27 0.28* 
AP GRF Maximum 1 0.12 -0.11 -0.13 -0.14 
AP GRF Maximum 2 -0.44* 0.42* 0.38* 0.44* 
AP GRF Minimum 1 0.34* -0.15 -0.21 -0.26 
AP GRF Minimum 2 0.38* -0.05 -0.06 -0.16 
*indicates P<0.05 
COP=center of pressure; GRF=ground reaction force; WOMAC= Western Ontario and 
McMaster Universities Arthritis Index; 1=first 50% of stance phase; 2=second 50% of stance 
phase; V=vertical; ML=mediolateral; AP=anteroposterior 
Table 4. Baseline COP correlations with subject characteristics 
 Maximum 
Gait Speed 
(s) 
Stance Time 
(s) 
Ellipse Area 
(cm2) 
Sway Path 
(cm) 
Sway 
Velocity 
(cm/s) 
Pain (VAS, cm) -0.09 -0.15 0.16 -0.02 -0.03 
WOMAC -0.24 -0.03 0.2 -0.11 -0.14 
CAR -0.12 0.10 -0.14 0.07 -0.06 
KL Score 0.20 -0.7 0.01 0.00 -0.14 
Height (m) -0.17 -0.02 -0.21 0.21 0.08 
Weight (kg) 0.04 0.05 -0.08 0.19 -0.04 
*indicates P<0.05 
COP = center of pressure; WOMAC=Western Ontario and McMaster Universities Arthritis 
Index; CAR = central activation ratio; KL=Kellgren-Lawrence; VAS=visual analog scale 
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positive correlation with M displacement shows that the COP has greater movement medially, 
while L displacement shows that the COP has less movement laterally. An increase in ML 
excursion would result from an increase in M displacement and a decrease in L displacement.  
Table 5. Baseline DEXA correlation coefficients with COP displacement 
 ML Excursion (cm) L Displacement (cm) M Displacement (cm) 
Total Mass (kg) 0.85* 0.27 0.89* 
Total Body Fat Percent -0.08 -0.85* -0.46 
Total Fat Mass (kg) 0.59 -0.75 0.18 
Total Lean Mass† (kg) 0.87 0.92* 0.95* 
Total Mass Legs† (kg) 0.71 0.78 0.78 
Fat Mass Legs† (kg) -0.68 -0.78 -0.77 
Lean Mass Legs† (kg) 0.84 0.95* 0.94* 
*indicates P<0.05; †indicates n=5 
BMI = body mass index; CAR = central activation ratio; COP = center of pressure; ML = 
mediolateral 
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CHAPTER 5: DISCUSSION 
The aim of this study was to assess the change in gait speed and COP characteristics 
following a 4 week intervention and determine their association with participant characteristics. 
Following intervention, subjects had a significant improvement in pain and WOMAC score, as 
well as maximum gait speed, assessed using the 20 meter walk test score. Improved GRF scores 
following intervention included increased maximum and minimum AP GRFs during the second 
and first half of the gait cycle, respectively. Change score correlations indicated that only 
maximum gait speed was inversely related to COP sway velocity. These results contribute to the 
literature on KOA and the impact of common treatment methods, showing that not only can 
maximum gait speed improve following intervention, but the health of the effected leg improves 
since they are able to have higher propulsive and braking forces. 
To compare the relationship between gait speed and gait stability, several correlation 
coefficients were calculated. These were done using the baseline values and change score values 
with maximum gait speed, stance time, COP sway path, COP sway velocity being the variables 
of primary interest. Maximum gait speed increased following the intervention, as expected based 
on another study which included a slightly longer intervention of 6 weeks and showed an 
increase in gait speed of nearly the same magnitude70. Maximum walking speed has been shown 
to be a reliable measure in gait testing, specifically in KOA patients71.  
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Baseline and change score values of gait speed were negatively correlated with baseline 
and change score values of COP sway velocity. Increased COP sway velocity has been used in 
previous studies to measure decreased stability10 69. These inverse relationships support other 
research showing that a slower walking speed is not more stable41 72. The loss of stability 
indicated with higher COP velocity may be the result of increased ML COP velocity. However, 
we were unable to differentiate between ML and AP COP velocity in our current study, allowing 
this to remain speculative and an area for further study. 
Although stance time and gait speed changed as expected with stance time decreasing as 
speed increased, they were not significantly correlated to each other. Both variables were 
compared to GRF variables to further explore gait changes that occurred. APGRF minimum 
during the first and second 50% of stance phase were positively correlated with gait speed, 
supporting previous literature73, and indicating an increased braking force upon initial contact 
and as weight shifts to the forefoot. As suggested by Peterson et al., an increase in posterior GRF 
indicates a healthier gait cycle since it is a mechanism by which gait is controlled73. The 
maximum MLGRF, which is negatively correlated with stance time, indicates there is a greater 
medial force. The negative correlation may not be due to an increase in overall GRF, but rather a 
greater posterior force in the first and second half of stance phase. If the posterior force is a 
higher relative proportion of the total force, the medial force would consequently decrease. 
The secondary research question addressed by the study explored the relationship 
between subject characteristics such as pain, WOMAC score, CAR, and body composition to 
gait speed. In this study, no significant baseline correlations with these variables and maximum 
gait speed were found.  
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FM is women and LM in men have previously been linked to the presence of KOA22 23. 
In an exploratory analysis of body composition measure via DEXA (N=7), both total body lean 
mass and lower extremity lean mass were significantly correlated with an increased L and M 
COP displacement. A greater M COP displacement value indicates that the COP is further 
medially, whereas a greater L COP displacement indicates that the COP travels laterally to a 
lesser extent. Greater medial movement of the COP may not necessarily indicate a decline in 
COP trajectory. Instead, the increased displacement may suggest that as the lean tissue increases, 
force production also increases52, and the COP moves to a greater extent because there is now a 
greater ability to control movement laterally without a loss of balance. Improved balance will 
consequently result in better physical function and increase quality of life. However, due to a 
small sample size that completed DEXA scans, we are unable to fully address this question at 
this time. However, this question should be reevaluated with a larger sample and subjects 
ranging from healthy controls to severe KOA patients. 
The study was limited due to its reliance on the subject walking at a maximum gait speed 
at each visit. The gait speed selected may be influenced by factors other than the intervention 
such as fatigue and pain from activities other than TE. Subjects were also asked to self-report for 
pain and WOMAC scores. Each individual’s interpretation of “mild”, “moderate”, or “severe” 
may differ on these questionnaires, but the WOMAC has been established as a valid assessment 
of dysfunction for KOA patients. The implications from the change in COP velocity were also 
limited because we could not differentiate between ML and AP COP velocity through the Matlab 
code used. 
In summary, this study further explored the effects of common treatments used for KOA 
rehabilitation. Treatments are proven to be effective since following intervention, the maximum 
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gait speed increases and pain, and WOMAC scores decrease. Other meaningful implications 
come from the increased maximum AP GRF and the decreased minimum AP GRF, which 
indicate that the involved limb can withstand higher propulsive and braking forces after 
treatment. Further exploration is warranted to determine the implications of FM and LM on the 
gait cycle in KOA patients. However, this study contributes to the existing literature by 
expanding upon the treatment effects of TE and TENS in KOA, specifically that improvements 
in gait speed following treatment are concurrent with improvements in dynamic stability and 
allow KOA patients to complete activities of daily living while minimizing the fall risk. 
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University of North Carolina at Chapel Hill 
Consent to Participate in a Research Study 
Adult Participants  
Consent Form Version Date: 7-05-2016 
IRB Study # 15-1150 
Title of Study: The KNEEhabilitation Study: Improving Disability in Individuals with Knee 
Osteoarthritis 
Principal Investigator: Brian Pietrosimone 
Principal Investigator Department: Exercise and Sport Science 
Principal Investigator Phone number: 919-962-3617 
Principal Investigator Email Address: brian@unc.edu  
Co-Investigators: Todd Schwartz, Leigh Callahan, Troy Blackburn, Jeffrey Spang, Yvonne Golightly, 
Daniel Nissman, David Berkoff, Joanne Jordan, Robert Creighton, Daniel Del Gaizo, Ganesh Kamath, 
Darin Padua, Harry Stafford, Lauren Porras 
 
Funding Source and/or Sponsor: NATIONAL INSTITUTE OF ARTHRITIS AND 
MUSCULOSKELETAL AND SKIN DISEASES (NIAMS) 
 
Study Contact Telephone Number: 843-2014 
Study Contact Email: bluc@live.unc.edu 
 
_________________________________________________________________ 
 
What are some general things you should know about research studies? 
You are being asked to take part in a research study.  To join the study is voluntary. 
You may refuse to join, or you may withdraw your consent to be in the study, for any reason, without 
penalty. 
 
Research studies are designed to obtain new knowledge. This new information may help people in the 
future. You may not receive any direct benefit from being in the research study. There also may be risks 
to being in research studies. Deciding not to be in the study or leaving the study before it is done will not 
affect your relationship with the researcher, your health care provider, or the University of North 
Carolina-Chapel Hill (UNC). If you are a patient with an illness, you do not have to be in the research 
study in order to receive health care. 
 
Details about this study are discussed below.  It is important that you understand this information so that 
you can make an informed choice about being in this research study. You will be given a copy of this 
consent form. You should ask the researchers named above, or staff members who may assist them, any 
questions you have about this study at any time. 
 
What is the purpose of this study? 
Thigh muscle strength is important for improving function in individuals with knee osteoarthritis. There is 
evidence that stronger thigh muscles allow people with knee osteoarthritis to be more physically active 
and to do more activities without pain.  One cause of muscle weakness in individuals with knee 
osteoarthritis stems form the inability of nerves to “turn on” the muscles in the leg.  Physical therapy is 
one method for changing how those leg muscles “turn on”.  "There is some evidence that using 
transcutaneous electrical nerve stimulation (TENS), which is a commonly used form of electrical 
stimulation that can be put on your knee, may also help to “turn on” muscles in people who have muscle 
weakness.  The purpose of this research study is to test how TENS used with physical therapy and during 
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daily activities changes your ability to “turn on” your thigh muscles as well as how TENS and physical 
therapy may improve your thigh muscle strength, ability walk and perform activities of daily living, and 
potentially changes feelings about your knee function.  We are evaluating the effect of TENS and 
physical therapy in people with knee osteoarthritis, who feel some disability related to knee function and 
have difficulty turning “their muscles on”. You are being asked to be in the study because you have been 
diagnosed with knee osteoarthritis, you feel some limitations in performing activities because of you have 
been diagnosed with knee osteoarthritis.  
 
Are there any reasons you should not be in this study? 
You should not be in this study if you have: 1) been diagnosed with a cardiovascular condition restricting 
you from participating in exercise; 2) had a corticosteroid or hyaluronic acid injection in your knee in the 
past 2-weeks; 3) a pacemaker; 4) a neurodegenerative condition; 5) rheumatoid arthritis; 6) cancer; 7) 
neural sensory dysfunction over the knee 8) a BMI over 35; 9) history of lower extremity orthopaedic 
surgery in the past year; 10) a history of a traumatic knee injury in the past 6 months; 11) any history of a 
total knee arthroplasty (or joint replacement)  in either extremity; or 12) a diagnosed, non-reconstructed 
knee ligament tear.  Also you should not be in this study if you need an assistive device, such as a cane or 
walker, to walk.  You should not be in this study if you are currently pregnant or plan to become pregnant 
during this study.  
 
How many people will take part in this study? 
A total of approximately 177 people may be screened to participate in this study while 90 people with knee 
osteoarthritis from this institution will be enrolled in the intervention portion of the study. 
 
 
How long will your part in this study last? 
The study will consist of a screening/ baseline session, 10 visits of physical therapy over 4-weeks, as well as two 
follow-up tests at 4 and 8 weeks after beginning your first physical therapy visit.  The screening session will last 
approximately 1 hour.  If you qualify for the study and still would like to participate, we will conduct a few extra 
measurements over an additional 1-hour as part of the baseline session. Each of the 10 physical therapy sessions will 
last 45-60 minutes. Each of the two follow up testing session will consist of two 1.5 hour sessions at time points 
occurring at 4 and 8-weeks after your first physical therapy session.  
 
What will happen if you take part in the study? 
 
If you decide to take part in this study, you will be assigned to receive a study group that is provided a 
TENS unit and physical therapy or a group that only receives physical therapy.  
Once included, you will be asked to report to the Sports Medicine Research Laboratory (SMRL) 
Laboratory in Fetzer Hall at the University of North Carolina at Chapel Hill for 3 separate testing sessions 
and to the UNC Meadowmont Physical Therapy Clinic for 10 supervised physical therapy sessions.   
Testing Session 1 (will last approximately 2 hours) will consist of a screening and eligibility session 
where you will first complete the Western Ontario and McMaster Universities Osteoarthritis index 
(WOMAC) questionnaire as well as a Thigh Muscle Function Assessment. If your outcomes from 
these two measurements meet the inclusion criteria we will ask you to sign a HIPPA form, which will 
allow our study team to determine the severity of your knee osteoarthritis based on the last knee x-ray in 
your UNC Medical Records. If you are not eligible for the study at this point you will be excluded.  
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If you are eligible for the study at this point we will conduct a few additional tests during session one that 
include knee pain and physical activity surveys, a thigh muscle function assessment, knee range of motion 
assessment, gait biomechanics assessment and a physical performance assessment.    
 
Testing Sessions 2 and 3 (will last approximately 1.5 hours each) will consist of questionnaires and 
surveys about your knee function, pain and physical activity as well as the thigh muscle function 
assessment, knee range of motion assessment, gait biomechanics assessment and a physical performance 
assessment. Testing sessions 2 and 3 will take place 4 and 8-weeks after your first physical therapy 
session. 
Body Composition Assessment 
During each lab visit, you will have a DEXA full body scan which will measure your fat free mass, fat 
mass, and bone mineral content. A DEXA uses minimal amounts of radiation, the test lasts 6 minutes and 
requires you to lie on the table and remain still. 
 
Thigh Muscle Function Assessment 
Similar to the screening measurement, you will be asked to perform maximal contractions of the 
quadriceps muscle on the front of your thigh. You will be seated and asked to kick out your leg as hard as 
you can against a device that measures how much force you can produce.  During the contraction, a very 
brief (less than 1/1,000th of a second) pulse of electricity will be sent to your quadriceps muscle.  This 
pulse of electricity will allow us to measure muscle function and is similar to a strong “carpet shock”.  
You will be allowed to perform at least 2 practice trials to become comfortable and familiar with the 
electrical stimulus, after which 3 trials will be recorded. You will similarly be asked to push your heel 
into the pad without an electric pulse as you sit in the chair and side lie on a table.   
 
Range of Motion Testing  
We will test how far you are able to bend and straighten your knee as you lie down on a table. 
 
Gait Biomechanics Assessment 
You be asked to walk forward along a 20 foot walkway at a comfortable, self-selected speed over a 
device called a force plate that is embedded in the walkway.  You will perform at least 5 practice trials to 
ensure that you are comfortable walking over the force plate with a natural stride and without “aiming” 
for the force plate.  We will put small reflective markers on different parts of your legs which will allow 
cameras in the SMRL to track how your knees move while you walk.  
 
Performance Testing  
You will be asked to do three different performance tests.  
The first is a chair stand test, in which you will start seated in a chair and we will count how many times 
you can stand up and sit down in a 30 second period.  Next, we will determine how fast you can 
comfortable walk forty-meters. We will time you 3 times (with at least a 1-minute rest period in between 
each trial).  Finally we will test how fast you can climb 10 stairs at a fast but comfortable pace and you 
will be timed with a stopwatch. We will time 3 trials with at least a 1-minute rest period in between each 
trial.  
 
Physical Therapy Intervention at the UNC Meadowmont Clinic 
The physical therapy intervention will consist of 10 sessions supervised by a Licensed Physical Therapist 
at the UNC Meadowmont Clinic. Additionally, you may be randomized into a group that receives a 
Transcutaneous Electrical Stimulation (TENS) unit in combination to the 10 physical therapy sessions 
(over four weeks) of physical therapy. Being randomized into a group that receives a TENS stimulator 
means that you will be assigned by chance, like flipping a coin. This is a blinded trial which means we 
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will ask that you do not tell the investigator that will be collecting data from you in the SMRL what 
intervention you received.  You can always contact the study coordinator Brittney Luc, or the Principal 
Investigator Brian Pietrosimone about the TENS unit. 
 
Physical Therapy 
All groups will complete a standardized rehabilitation program.  You will receive therapeutic exercise 2 
to 3 times per week for a total of 10 sessions over a 4 week period. Ten physical therapy sessions over a 
4-week period is the current standard of care for patients with knee osteoarthritis at our facility. A lower 
extremity physical assessment will be conducted bilaterally for each participant to identify deficits and 
establish clinical baseline measures prior to beginning rehabilitation and following the 4 -week 
intervention.  The goals of the therapeutic exercise program are to increase thigh muscle strength and 
your ability to do activities of daily living.    
 
Being Randomized to a TENS group with Physical Therapy 
If you are randomized into a TENS group, you will receive a Select System TENS unit, self-adhesive 
electrodes and batteries.  A licensed health care professional will assist you in applying the electrodes on 
the knee joint and will educate you on how to operate the TENS unit. An instruction manual will be 
provided to you for reference purposes explaining operation of the device. The sensation of the electrical 
stimulation may vary among people. The strength of the perceived stimulation will vary among subjects 
from little or nothing to modest tingling, depending on the dosing you are randomized to receive.  You 
will also complete the standardized physical therapy program under the supervision of your physical 
therapist at the UNC Meadowmont Clinic. The TENS unit will be worn during all therapeutic exercise 
sessions and at least 8 hours per day when you are the most active. We will ask you to keep a log that will 
indicate how long you wore the TENS unit each day.  We will collect the log from you at the end of each 
week as well as ask you how well you are tolerating the intervention each week (you will indicate this on 
a questionnaire form).  
 
Not Being Randomized to a TENS group with Physical Therapy  
If assigned, you will still receive the standard of care of therapeutic strengthening exercises for the 10 
sessions over the 4-week period.  You will not be provided with any TENS unit.  
What are the possible benefits from being in this study? 
Research is designed to benefit society by gaining new knowledge. The benefits to you from being in this 
study may be that you may increase the strength of your leg muscles, which may result in less knee pain 
and less disability compared to what you may have experienced before you started the study.  
  
What are the possible risks or discomforts involved from being in this study? 
Exercise in general, including therapeutic exercise performed in physical therapy, carries the risk of pain 
and soreness/discomfort.  As such, you may experience soreness in your leg muscles from the physical 
therapy or the thigh muscle assessment/ performance testing.  It is also possible, though highly unlikely, 
that you could injure a muscle or your knee during these contractions.  The tasks you will be asked to 
perform in this study are common to activities of daily living, rehabilitative exercises, and strength 
training exercises, and do not place you at greater risk of injury compared to these same tasks when you 
perform them during daily activity and your regular exercise routine.  You may also experience mild 
discomfort for a brief period of time (less than 1 second) during the electrical stimulation used during the 
thigh muscle function assessment.  You will be familiarized with the electrical stimulation to ensure you 
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are comfortable with it before the testing procedures begin. There is also a possibility of acquiring some 
mild, transient skin irritation from the sticky TENS electrodes if you are randomized to the TENS group. 
There may be uncommon or previously unknown risks. You should report any problems to the principal 
investigator, Brian Pietrosimone.  
 
What if we learn about new findings or information during the study?  
You will be given any new information gained during the course of the study that might affect your 
willingness to continue your participation.  
 
How will information about you be protected? 
Any information obtained in connection with this research study that can be linked to you will remain 
confidential. You will be identified only by a subject identification number.  A code list that associates 
your name and information with a specific subject identification number will be kept under lock-and-key 
on a password-protected computer in the Neuromuscular Research Laboratory. Only the research team 
will have access to this information. Participants will not be identified in any report or publication about 
this study. Although every effort will be made to keep research records private, there may be times when 
federal or state law requires the disclosure of such records, including personal information.  This is very 
unlikely, but if disclosure is ever required, UNC-Chapel Hill will take steps allowable by law to protect 
the privacy of personal information.  In some cases, your information in this research study could be 
reviewed by representatives of the University, research sponsors, or government agencies (for example, 
the FDA) for purposes such as quality control or safety. 
 
What will happen if you are injured by this research? 
All research involves a chance that something bad might happen to you.  This may include the risk of 
personal injury. In spite of all safety measures, you might develop a reaction or injury from being in this 
study. If such problems occur, the researchers will help you get medical care, but any costs for the 
medical care will be billed to you and/or your insurance company. The University of North Carolina at 
Chapel Hill has not set aside funds to pay you for any such reactions or injuries, or for the related medical 
care. You do not give up any of your legal rights by signing this form. 
 
What if you want to stop before your part in the study is complete? 
You can withdraw from this study at any time, without penalty.  The investigators also have the right to 
stop your participation at any time. This could be because you have had an unexpected reaction, or have 
failed to follow instructions, or because the entire study has been stopped. 
 
Will you receive anything for being in this study? 
You will receive all physical therapy associated with this study free of charge.  
You will be compensated a total of $100 for attending all three outcomes assessments. You will not be 
compensated for the screening portion of the study. After screening into the study, you will be 
compensated $20 for baseline measurements and $40 for the 4-week and 8-week post-baseline testing 
sessions. You will be compensated after your last completed outcome session study. Compensation will 
be in the form of a $100 Visa gift card. 
 
Will it cost you anything to be in this study? 
It will not cost you anything to be in this study.  All physical therapy sessions will be fully reimbursed by 
the grant supported by the National Institutes of Health (NIAMS).   
 
Who is sponsoring this study? 
This research is funded by the National Institutes of Health.  This means that the research team is being 
paid by the sponsor for doing the study.  The researchers do not, however, have a direct financial interest 
with the sponsor or in the final results of the study. 
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What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this research. If you 
have questions, complaints, or concerns about the study; or if a research-related injury occurs, you should 
contact the researchers listed on the first page of this form. 
 
A description of this clinical trial will be available on www.clinicaltrials.gov, as required by U.S. Law. 
This website will not include information that can identify you. At most, the website will include a 
summary of the results. You can search this website at any time. 
 
What if you are a UNC employee? 
Taking part in this research is not a part of your University duties, and refusing will not affect your 
job.  You will not be offered or receive any special job-related consideration if you take part in this 
research 
 
What if you have questions about your rights as a research participant? 
All research on human volunteers is reviewed by a committee that works to protect your rights and 
welfare.  If you have questions or concerns about your rights as a research subject, or if you would like to 
obtain information or offer input, you may contact the Institutional Review Board at 919-966-3113 or by 
email to IRB_subjects@unc.edu. 
Participant’s Agreement: 
 
I have read the information provided above.  I have asked all the questions I have at this time.  I 
voluntarily agree to participate in this research study. 
 
______________________________________________________ 
Signature of Research Participant 
 
____________________ 
Date 
 
______________________________________________________ 
Printed Name of Research Participant 
  
 
______________________________________________________ 
Signature of Research Team Member Obtaining Consent 
 
____________________ 
Date 
 
______________________________________________________ 
Printed Name of Research Team Member Obtaining Consent 
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